In a 6-week randomized, double-blind, placebo-controlled trial, participants taking 200 mg/day of ButyraGen® reported meaningful improvements in psychological well-being.
A First-of-its-Kind Study Proving The Gut-Brain Connection
What Is ButyraGen®
ButyraGen® is a novel dual-action biotic designed to deliver targeted, next-generation digestive support. This clinically researched, patent-pending ingredient combines prebiotic fibers with tributyrin to support gut, digestive, and cognitive health.
ButyraGen® has demonstrated significant benefits across multiple aspects of digestive health, including reductions in occasional belly pain and improvements in symptoms associated with both upper and lower gastrointestinal distress.
Beyond digestive health, ButyraGen® has been clinically shown to influence the gut-brain axis. By addressing both digestive and gut-brain health, ButyraGen® offers a differentiated and comprehensive, science-backed solution for consumers, supporting an improved quality of life.
Butyrate: A Small Molecule with a Big Impact
Butyrate is a naturally occurring short-chain fatty acid (SCFA) essential for gut health and systemic balance. Butyrate plays a critical role in the body supporting intestinal barrier function, immune signaling, and cellular energy production, and has been shown to influence the gut-brain axis by supporting signaling pathways that communicate with the brain.
Mechanism of Action
Unlike traditional fiber-based approaches that rely solely on microbial fermentation, ButyraGen® delivers a more efficient and predictable pathway to butyrate production, helping to nourish colonocytes, reinforce tight junctions, and support gut-barrier integrity.
While the prebiotic fibers help nourish beneficial bacteria, tributyrin is converted into butyrate in the small intestine, providing a direct and sustained source of butyrate.
The Gut-Brain Axis
The gut-brain axis operates through neural, hormonal, and biochemical signals, including microbial metabolites like SCFAs. Butyrate acts as a histone deacetylase (HDAC) inhibitor, modulating gene expression and improving oxidative stress response. Emerging evidence suggests that butyrate supports neuroprotection, enhances neuroplasticity, and may influence mood regulation, making it a promising candidate for cognitive and emotional health.
Study Summary
In a 6-week randomized, double-blind, placebo-controlled trial (N=596), participants taking 200 mg/day of ButyraGen® reported meaningful improvements in psychological well-being. Outcomes were assessed using validated questionnaires for anxiety, depression, and digestive quality of life (DQLQ). Significance appeared in week 2 and continued through the 6 week study, highlighting both fast acting and durable benefits.
Feelings of Depression
Participants with a healthy GI system showed a statistically significant, 2-fold greater likelihood of improvement compared to the placebo (p=0.011). Similarly, younger adults (<40 years) exhibited significant improvements in feelings of hopelessness, helplessness, and depression (p=0.031, 0.022, 0.040).
Feelings of Anxiety
Significant reductions in feelings of fear and unease across all participants was observed, with Men more than twice as likely to achieve clinically meaningful improvement (p=0.007). Additionally, a non-significant, but meaningful trend in anxiety scores was observed in the general population.
Quality of Life
Active group participants reported reduced distraction (17.15% lower rate) and greater willingness to engage in social activities (12.16% higher rate), indicating improvements in daily functioning. This suggests a potential modulation to the gut-brain axis through physiological gut health improvements.
Conclusion
These findings suggest that ButyraGen® may support psychological well-being through two complementary gut-brain pathways: indirectly via vagal, immune, and hormonal signaling, and directly via butyrate crossing the blood-brain barrier influencing neurotransmitter synthesis and gene expression, contributing to mood regulation and cognitive resilience.
Interested In Learning More About ButyraGen®?
Fill out the form below and a member of the NutriScience team will be in touch shortly!
ButyraGen® In The News
A Novel, Clinically Validated Approach to Supporting Psychological Well-Being
January 21, 2026 Nutraceuticals World
Clinical trial finds prebiotic complex significantly reduces belly pain in adults with GI issues
July 8, 2025 - Nutritional Outlook
